Asset Management One’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$177M Sell
1,380,043
-61,263
-4% -$7.17M 0.46% 39
2026
Q1
$173M Buy
1,441,306
+91,333
+7% +$10.5M 0.51% 31
2025
Q4
$144M Buy
1,349,973
+9,397
+0.7% +$882K 0.4% 45
2025
Q3
$113M Buy
1,340,576
+55,089
+4% +$4.54M 0.33% 50
2025
Q2
$102M Sell
1,285,487
-7,134
-0.6% -$567K 0.32% 55
2025
Q1
$116M Buy
1,292,621
+22,556
+2% +$2.11M 0.4% 41
2024
Q4
$127M Buy
1,270,065
+6,779
+0.5% +$699K 0.44% 35
2024
Q3
$143M Buy
1,263,286
+25,257
+2% +$3M 0.51% 29
2024
Q2
$153M Sell
1,238,029
-28,211
-2% -$3.63M 0.59% 25
2024
Q1
$167M Sell
1,266,240
-31,801
-2% -$3.92M 0.64% 24
2023
Q4
$141M Sell
1,298,041
-92,421
-7% -$9.59M 0.57% 26
2023
Q3
$143M Sell
1,390,462
-37,150
-3% -$4M 0.64% 25
2023
Q2
$165M Sell
1,427,612
-16,886
-1% -$1.92M 0.7% 23
2023
Q1
$154M Buy
1,444,498
+11,614
+0.8% +$1.25M 0.7% 21
2022
Q4
$159M Sell
1,432,884
-21,104
-1% -$2.16M 0.77% 18
2022
Q3
$125M Sell
1,453,988
-17,137
-1% -$1.53M 0.64% 24
2022
Q2
$134M Buy
1,471,125
+85,486
+6% +$7.58M 0.63% 25
2022
Q1
$114M Sell
1,385,639
-64,183
-4% -$5.06M 0.44% 39
2021
Q4
$112M Buy
1,449,822
+36,854
+3% +$2.94M 0.39% 49
2021
Q3
$106M Sell
1,412,968
-32,405
-2% -$2.46M 0.41% 44
2021
Q2
$112M Sell
1,445,373
-86,520
-6% -$6.44M 0.42% 39
2021
Q1
$113M Sell
1,531,893
-140,751
-8% -$10.4M 0.45% 35
2020
Q4
$130M Buy
1,672,644
+3,634
+0.2% +$278K 0.54% 28
2020
Q3
$132M Sell
1,669,010
-46,180
-3% -$3.62M 0.61% 28
2020
Q2
$127M Buy
1,715,190
+36,286
+2% +$2.73M 0.62% 25
2020
Q1
$123M Sell
1,678,904
-61,423
-4% -$4.83M 0.72% 24
2019
Q4
$151M Sell
1,740,327
-39,388
-2% -$3.24M 0.68% 26
2019
Q3
$143M Sell
1,779,715
-32,541
-2% -$2.61M 0.69% 23
2019
Q2
$145M Buy
1,812,256
+137,091
+8% +$10.5M 0.71% 23
2019
Q1
$133M Sell
1,675,165
-3,272,240
-66% -$245M 0.72% 19
2018
Q4
$360M Buy
4,947,405
+133,456
+3% +$9.42M 0.86% 19
2018
Q3
$326M Buy
4,813,949
+68,495
+1% +$4.36M 0.67% 29
2018
Q2
$275M Buy
4,745,454
+25,056
+0.5% +$1.41M 0.6% 31
2018
Q1
$245M Sell
4,720,398
-9,364
-0.2% -$506K 0.55% 35
2017
Q4
$254M Sell
4,729,762
-33,995
-0.7% -$1.88M 0.56% 37
2017
Q3
$291M Buy
4,763,757
+9,562
+0.2% +$580K 0.68% 30
2017
Q2
$291M Buy
4,754,195
+8,487
+0.2% +$517K 0.74% 26
2017
Q1
$288M Sell
4,745,708
-359,223
-7% -$21.8M 0.76% 24
2016
Q4
$287M Buy
5,104,931
+4,631,350
+978% +$271M 0.73% 28
2016
Q3
$28M Sell
473,581
-44,431
-9% -$2.6M 0.42% 50
2016
Q2
$28.3M Buy
518,012
+44,374
+9% +$2.36M 0.42% 49
2016
Q1
$24M Buy
473,638
+8,279
+2% +$405K 0.35% 56
2015
Q4
$23.6M Sell
465,359
-34,541
-7% -$1.74M 0.35% 58
2015
Q3
$23.3M Buy
499,900
+345
+0.1% +$18.3K 0.35% 52
2015
Q2
$27.3M Sell
499,555
-47,848
-9% -$2.68M 0.38% 47
2015
Q1
$30.4M Buy
547,403
+6,357
+1% +$360K 0.38% 49
2014
Q4
$29.7M Sell
541,046
-15,319
-3% -$853K 0.39% 40
2014
Q3
$31.5M Sell
556,365
-23,506
-4% -$1.32M 0.44% 34
2014
Q2
$31.9M Sell
579,871
-7,821
-1% -$427K 0.48% 35
2014
Q1
$31.5M Buy
587,692
+45,031
+8% +$2.33M 0.5% 39
2013
Q4
$25.8M Sell
542,661
-135,427
-20% -$6.19M 0.4% 48
2013
Q3
$30.9M Buy
678,088
+16,066
+2% +$734K 0.47% 43
2013
Q2
$29.8M Buy
+662,022
New +$29.6M 0.48% 44

Other funds holding MRK

Asset Management One's MRK Position: Q2 2026 in Review

Asset Management One reduced its Merck (MRK) stake by 4.3% in Q2 2026, selling an estimated $7.17M and leaving 1,380,043 shares worth $177M. The position accounts for 0.46% of the portfolio, ranked #39.

Asset Management One first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $360M in Q4 2018. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Asset Management One held 1,380,043 shares of Merck worth $177M as of Q2 2026.
  • Asset Management One sold 61,263 Merck shares in Q2 2026, an estimated $7.17M.
  • Merck made up 0.46% of Asset Management One's portfolio in Q2 2026, its #39 holding.
  • Asset Management One first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Asset Management One's Merck position peaked at $360M in Q4 2018.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.